menu
    • menu

    Company profile for Expression Therapeutics

    NEW Drugs in Dev: 3
    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Sigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Expression Therapeutics is a biotechnology company based in Atlanta. Our therapeutic pipeline includes advanced gene therapies for hemophilia A and B; neuroblastoma, T-cell leukemia/lymphoma, and acute myeloid leukemia (AML); and hematologic disorders such as hemophagocytic lymphohistiocytosis (HLH). Each product candidate has been specifically engineered using proprietary gene expression biotechnologies designed for optimal s...
    Expression Therapeutics is a biotechnology company based in Atlanta. Our therapeutic pipeline includes advanced gene therapies for hemophilia A and B; neuroblastoma, T-cell leukemia/lymphoma, and acute myeloid leukemia (AML); and hematologic disorders such as hemophagocytic lymphohistiocytosis (HLH). Each product candidate has been specifically engineered using proprietary gene expression biotechnologies designed for optimal safety and efficacy.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Expression TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1860 Montreal Road Tucker, GA 30084
    Telephone
    Telephone
    678-278-1140
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.expressiontherapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Expression Therapeutics Secures Rare FDA Approval for Hemophilia
    Expression Therapeutics Secures Rare FDA Approval for Hemophilia

    29 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/expression-therapeutics-receives-fda-fast-track-and-rare-pediatric-disease-designations-for-investigational-stem-cell-therapy-for-hemophilia-a-302756492.html

    PR NEWSWIRE
    29 Apr 2026
    Share Share
    Expression Therapeutics Names Industry Veteran David Townson
    Expression Therapeutics Names Industry Veteran David Townson

    10 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/expression-therapeutics-appoints-industry-veteran-dr-david-townson-as-chief-executive-officer-302636777.html

    PR NEWSWIRE
    10 Dec 2025
    Share Share
    Expression Therapeutics Unveils Hemophilia A Gene Therapy Results
    Expression Therapeutics Unveils Hemophilia A Gene Therapy Results

    11 Dec 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/expression-therapeutics-announces-promising-phase-1-results-for-groundbreaking-hemophilia-a-gene-therapy-at-ash-302328084.html

    PR NEWSWIRE
    11 Dec 2024
    Share Share
    Expression Therapeutics to Present at the 2022 BIO CEO & Investor Conference
    Expression Therapeutics to Present at the 2022 BIO CEO & Investor Conference

    08 Feb 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/expression-therapeutics-to-present-at-the-2022-bio-ceo--investor-conference-301477632.html

    PRNEWSWIRE
    08 Feb 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search